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Abstract
Background: The ability to synthesize chiral building block molecules with high optical purity is of considerable
importance to the fine chemical and pharmaceutical industries. Production of one such compound,
3-hydroxyvalerate (3HV), has previously been studied with respect to the in vivo or in vitro enzymatic
depolymerization of biologically-derived co-polymers of poly(3-hydroxybutyrate-co-3-hydroxyvalerate). However,
production of this biopolymeric precursor typically necessitates the supplementation of a secondary carbon source
(e.g., propionate) into the culture medium. In addition, previous approaches for producing 3HV have not focused
on its enantiopure synthesis, and thus suffer from increased costs for product purification.
Results: Here, we report the selective biosynthesis of each 3HV stereoisomer from a single, renewable carbon
source using synthetic metabolic pathways in recombinant strains of Escherichia coli. The product chirality was
controlled by utilizing two reductases of opposing stereoselectivity. Improvement of the biosynthetic pathway
activity and host background was carried out to elevate both the 3HV titers and 3HV/3HB ratios. Overall, shake-flask
titers as high as 0.31 g/L and 0.50 g/L of (S)-3HV and (R)-3HV, respectively, were achieved in glucose-fed cultures,
whereas glycerol-fed cultures yielded up to 0.19 g/L and 0.96 g/L of (S)-3HV and (R)-3HV, respectively.
Conclusions: Our work represents the first report of direct microbial production of enantiomerically pure 3HV from
a single carbon source. Continued engineering of host strains and pathway enzymes will ultimately lead to more
economical production of chiral 3HV.
Background
The efficient production of enantiomerically pure
chemicals from renewable resources has gained consid-
erable attention especially in the fine chemical/pharma-
ceutical industry. Stereo-selective chemical processes
generally employ expensive chiral catalysts, require
harsh physical conditions and solvents, and suffer from
extensive byproduct formation. In contrast, enzyme-cat-
alyzed reactions are highly stereo-selective and can be
performed in aqueous solutions under mild conditions
[1]. As a result, replacing chemical processes by biologi-
cal ones for the synthesis of chiral compounds has been
extensively investigated not only due to superior stereo-
selectivity of enzymatic reactions but also due to
sustainability as an implementation of green chemistry
[2-5]. One example is the production of hydroxyacids, a
family of versatile chiral molecules containing one
hydroxyl group and one carboxyl group [6]. These mole-
cules have the potential to serve as useful chiral building
blocks for a diverse range of products, including polyhy-
droxyalkanoates (PHAs) (biodegradable polymers) and
optically-active fine chemicals, such as pharmaceuticals,
vitamins, antibiotics, and flavor compounds [7-10].
Naturally, hydroxyacids are primarily found to be poly-
merized as PHAs where they serve as intracellular sto-
rage materials for numerous microbes. Those PHAs
consist mostly of monomers with 3-hydroxy, 4-hydroxy,
and 5-hydroxy groups with different lengths of main
and side chains [11].
Among the hydroxyacid monomers, 3-hydroxybutyrate
(3HB) is the most prolific, with several reports on engi-
neering E. coli for its production from renewable
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the condensation of two acetyl-CoA molecules, a com-
monly found cellular metabolite regardless of carbon
source (Figure 1). However, economically-feasible pro-
duction of longer-chain hydroxyacids is complicated by
issues such as low yields and high prices of feedstocks
due to the need to supplement a second carbon source.
One example of such hydroxyacids is 3-hydroxyvalerate
(3HV). The production of 3HV has been realized by the
hydroxylation of valeric acid through fermentation of
Candida rugosa [16]. It has also been reported that
3-hydroxyvaleronitrile can be converted into 3HV using
the nitrilase activity of Comamonas testosteroni [17].
More recently, direct biological production of 3HV was
demonstrated using recombinant P. putida KT2440 and
levulinic acid as substrate, although the levulinic acid
metabolism pathway in P. putida KT2440 has not yet
been fully elucidated [18]. In the aforementioned cases,
valeric acid, 3-hydroxyvaleronitrile, and levulinic acid
were supplied as secondary carbon sources (in addition
to glucose). Additionally, the chirality and/or enantio-
purity of the 3HV produced in the above-mentioned
studies is unclear as they did not report whether the
synthesized 3HV was in the R, S, or racemic form.
Alternatively, 3HV can be obtained through either the
in vivo or in vitro enzymatic depolymerization of synthe-
sized poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
(PHBV), a well known biodegradable polymer marketed
as Biopol™ which is produced by the natural PHA accu-
mulating bacterium Ralstonia eutropha when grown on
glucose and propionate [19]. The production of PHBV
has also been reported in recombinant E. coli upon
introduction of the PHA biosynthesis genes of R. eutro-
pha and when grown in glucose medium supplemented
with valine or threonine [20]. Regardless of whether the
end product is 3HV or PHBV, it can be generally con-
cluded that supplementation of a second carbon source,
such as valeric acid, 3-hydroxyvaleronitrile, levulinic
acid, propionate, valine, or threonine in addition to glu-
cose, is necessary to provide the 5-carbon unit precursor
of 3HV. Unfortunately, the high price and/or toxicity of
the added second carbon sources could limit industrial
production of 3HV [21]. Therefore, synthesis of 3HV
from a single carbon source has been proposed as an
efficient and sustainable avenue in contrast to the
above-mentioned systems.
A novel pathway for the production of PHBV solely
from glycerol has been established in recombinant Sal-
monella enterica Serovar Typhimurium, containing a het-
erologous pathway that converts succinyl-CoA to
propionyl-CoA, the essential precursor molecule of 3HV-
CoA in PHBV synthesis [22]. However, expensive cyano-
cobalamin (CN-B12) was supplemented to the medium to
provide the precursor of coenzyme B12 required for the
activity of one of the enzymes in the B12-dependent bio-
synthetic pathway. It should also be noted that the path-
w a yo n l yf u n c t i o n e di nS. enterica,ap a t h o g e n ,b u tn o t
E. coli, thus limiting its applicability to other industrially-
relevant host organisms. In this study, we proposed an
alternative biosynthetic pathway that does not require
coenzyme B12 for its functionality to synthesize 3HV
from glucose or glycerol. Specifically, we metabolically
engineered E. coli to exploit its native metabolism for
endogenous supply of propionyl-CoA via the threonine
biosynthesis pathway, and introduced a heterologous
pathway for chiral 3HV biosynthesis using acetyl-CoA
and propionyl-CoA as precursor molecules. As stated
above, several previous methods for producing 3HV did
not focus on enantiopure synthesis. Similarly, due to the
stereospecific constraints of PHBV synthesis, in which
polymers are composed exclusively of (R)-3HB and
(R)-3HV monomer units, the synthesis of (S)-3HV from
PHBV remains effectively impossible. On the contrary,
our proposed pathway makes possible the direct synth-
esis of both enantiomerically pure (R)-3HV and (S)-3HV.
We have identified a pathway which combines elements
of our previously developed chiral 3HB biosynthesis path-
way together with the natural threonine biosynthesis path-
way of E. coli for direct biosynthesis of chiral 3HV (Figure
1). In the proposed pathway, chiral 3HV is produced from
direct hydrolysis of 3HV-CoA catalyzed by a thioesterase
II (encoded by tesB)w h e r e3 H V - C o Ai so b t a i n e df r o m
condensation of one acetyl-CoA and one propionyl-CoA
to form 3-ketovaleryl-CoA catalyzed by a thiolase
(encoded by bktB), followed by a reduction of the 3-
ketovaleryl-CoA to 3HV-CoA catalyzed by a 3-hydroxybu-
tyryl-CoA dehydrogenase. Here, two enantio-selective
3-hydroxybutyryl-CoA dehydrogenases were utilized to
control the chirality of 3HV-CoA produced. The NADPH-
dependent dehydrogenase encoded by phaB produces (R)-
3HV-CoA while the NADH-dependent dehydrogenase
encoded by hbd produces (S)-3HV-CoA. It should be
noted that in order to yield the highest 3HV titers and
3HV/3HB ratios, BktB was used as the thiolase in this
study as opposed to other thiolases such as PhaA from R.
eutropha H16 or Thil from C. acetobutylicum ATCC 824
because BktB has been shown to have highest in vitro
enzyme activity towards the C5 substrate while PhaA and
Thil were specific towards the C4 substrate [19]. Next, a
pathway allowing for endogenous propionyl-CoA synthesis
from glucose or glycerol, through the threonine metabolic
pathway intermediate 2-ketobutyrate, was introduced to
circumvent the need for feeding propionate. To examine
the upstream pathway for endogenous supply of propio-
nyl-CoA, we used a bottom-up approach where 2-ketobu-
tyrate and threonine were, at first, fed to provide
propionyl-CoA, in addition to glucose, to support 3HV
production. In the final stage, a single carbon source of
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Page 2 of 12Figure 1 Schematic representation of chiral 3HV production via the threonine biosynthesis pathway in metabolically engineered
E. coli. Genes in bold are overexpressed while disrupted pathway steps are indicted by the “no” symbols. The carbon sources and main
metabolic products in the system are enclosed by rectangular boxes with thick and thin lines, respectively. For glycerol utilization [43,44], a
glycerol kinase (GK) phosphorylates glycerol to glycerol-3-phosphate, followed by oxidation to dihydroxyacetone phosphate that enters
glycolysis. The oxidation reaction is catalyzed by a membrane enzyme called glycerol-3-phosphate dehydrogenase (GlpD) with concomitant
production of ubiquinol (UQH2) from ubiquinone (UQ). Electrons stored in the ubiquinol are then transferred through the aerobic respiratory
chain coupled with proton translocation from cytoplasm to periplasm. Both ATP and NADPH can be synthesized by an H
+-driven proton
movement from periplasm to cytoplasm, catalyzed by an ATP synthase and a membrane-bound transhydrogenase (PntAB), respectively.
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Page 3 of 12glucose or glycerol was used to provide both acetyl-CoA
and propionyl-CoA to support 3HV biosynthesis in our
metabolically engineered E. coli.
Overall, in this study we successfully demonstrated the
direct biological production of enantiomerically pure
(R)-3HV and (S)-3HV from a single carbon source.
Improvements of the biosynthetic pathway and E. coli
host strains have also been carried out to elevate 3HV
titers and 3HV/3HB ratios.
Results
3HV Synthesis from Glucose and propionate
Acetyl-CoA is an obligate central intermediate occurring
in any organism and under any physiological condition;
however, this is not the case for propionyl-CoA, which
is only synthesized under special physiological condi-
tions and from only few substrates [23]. Therefore,
synthesis of 3HV-CoA requires propionyl-CoA biosynth-
esis. To validate our 3HV biosynthesis pathway, propio-
nate was initially fed to provide propionyl-CoA as a
precursor molecule to ensure the downstream pathway
was capable of making chiral 3HV. It has been reported
that the R. eutropha PHA biosynthesis genes can be
functionally expressed in E. coli, resulting in homopoly-
mer PHB production from glucose [24]. However, low
levels of 3HV monomer within the synthesized co-poly-
mer PHBV was observed in recombinant E. coli when
propionate was co-fed with glucose in a way analogous
to the procedure used for R. eutropha [24]. One expla-
nation for the low content of 3HV monomer is that
E. coli does not possess an efficient system for importing
and/or converting propionate to propionyl-CoA. There-
f o r e ,t oa d d r e s st h ep r o p i o n a t eu t i l i z a t i o np r o b l e m ,a
CoA-activation mechanism (encoded by the ptb-buk
operon [25]) was incorporated into our previously devel-
oped 3HB pathway to investigate the substrate elasticity
of the pathway for 3HV production.
Our results show that, in the absence of the CoA-acti-
vation mechanism, i.e. Ptb-Buk, only trace amount of
3HV was produced (Figure 2). On the contrary, introdu-
cing Ptb-Buk into the pathway yielded up to 2 g/L of
both enantiomers of 3HV. It was noted that for strains
expressing Ptb-Buk but leaving out TesB, only (R)-
hydroxyacids (when PhaB was employed) were pro-
duced, consistent with a previous report that Ptb-Buk
forms a reversible, stereo-seletive enzyme system [13].
Overall, these results indicate that CoA-activation was
crucial for propionate utilization and, most importantly,
all enzymes originally utilized for 3HB biosynthesis were
able to catalyze synthesis of C5 molecules.
3HV Synthesis from Glucose and 2-Ketobutyrate
Propionyl-CoA can also be produced from 2-ketobuty-
rate, a common keto-acid intermediate for isoleucine
biosynthesis, by the action of the endogenous pyruvate
dehydrogenase complex enzyme (encoded by PDHc)
(Figure 1) [26]. We first compared 3HV production
from glucose and 2-ketobutyrate using pathways with
and without over-expression of the ptb-buk operon. The
results showed that the presence of Ptb-Buk reduced
production of propionate (only observed in the R-isomer
construct) and 3HB while increasing production of acet-
ate and 3HV, yielding (S)-3HV and (R)-3HV with titers
up to 0.38 g/L and 1.02 g/L, respectively (Figure 3). The
increased production of acetate and 3HV was presum-
ably due to the promiscuous activity of Ptb-Buk on
cleaving excess acetyl-CoA and activating excess propio-
nate. Given that 3HB production is a second-order reac-
tion that should have a rate proportional to the square
of the concentration of acetyl-CoA, a reduced acetyl-
CoA pool resulting from the promiscuous activity of
Figure 2 3HV biosynthesis from glucose and propionate.T h i s
figure shows shake-flask production of chiral 3HV by recombinant
E. coli strain HCT 10 grown in LB supplemented with 20 g/L glucose
and 20 mM sodium propionate. Over-expressed genes are indicated
in the table below the graph.
Figure 3 3HV biosynthesis from glucose and 2-ketobutyrate.
This figure shows shake-flask production of chiral 3HV by
recombinant E. coli grown in LB supplemented with 20 g/L glucose
and 3 g/L sodium 2-ketobutyrate. Effects of overexpressing ptb-buk
and using acetate pathway knockout strain HCT 20 (with additional
deletions of ackA-pta. poxB, and atoDA genes compared to HCT 10)
on 3HV production are compared. All strains contained the same
set of plasmids pET-PB-B, and pCDF-T-H (for (S)-3HV synthesis) or
pCDF-T-P (for (R)-3HV synthesis).
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duction. In addition, propionyl-CoA is a competing sub-
strate for BktB, so an increase in propionyl-CoA
concentration may also reduce 3HB production.
In an effort to decrease acetate and increase 3HV pro-
duction, several genes, including atoDA (encoding acet-
oacetyl-CoA transferase), poxB (encoding pyruvate
oxidase), and ackA-pta (encoding acetate kinase and
phosphate acetyltransferase) were deleted, and the
resulting strain was designated as HCT 20. The produc-
tion of (S)-3HV and (R)-3HV was further boosted to
titers of 0.60 g/L and 2.04 g/L, respectively, in the
recombinant acetate pathway knockout strains (HCT
20). In general, those strains produced less acetate and
propionate and yielded more 3HB and 3HV compared
to strains without these mutations (based on HCT 10),
probably due to preserved acetyl-CoA and propionyl-
CoA pools as a result of the introduced mutations. An
empty-plasmid control experiment has also been con-
ducted in the strain HCT 20 (that was not introduced
with the 3HV pathway), yielding only trace amounts of
acetate and propionate when grown in LB supplemented
with glucose and 2-ketobutyrate (data not shown). This
indicates that the production of acetate and propionate
in the recombinant HCT 20 was attributed to the intro-
duced CoA-cleaving activity conferred by ptb-buk and
tesB.
3HV Synthesis from Glucose and Threonine
The metabolic intermediate 2-ketobutyrate can be pro-
duced from threonine by the action of threonine deami-
nase. Co-feeding of threonine with glucose, together
with over-expression of E. coli threonine deaminase
(encoded by ilvA), was able to achieve production of
(S)-3HV and (R)-3HV with titers up to 0.11 g/L and
0.22 g/L, respectively (Figure 4). Given that E. coli
threonine deaminase is subject to feedback inhibition by
isoleucine, a feedback resistant gene from Corynebacter-
ium glutamicum [27] was also used, and the production
of (S)-3HV and (R)-3HV was further boosted to titers of
0.27 g/L and 0.91 g/L, respectively, under the same cul-
ture conditions. This experiment has also been con-
ducted in the recombinant acetate pathway knockout
strains (HCT 20); however, no improvement in produc-
tion of 3HB and 3HV was observed (data not shown).
3HV Synthesis from Glucose
We have demonstrated the production of chiral 3HV
from glucose supplemented with propionate, 2-ketobu-
tyrate, or threonine, in recombinant E. coli.T h en e x t
step is to construct a threonine over-producing strain in
an attempt to achieve 3HV biosynthesis from a single
carbon source. To do so, we up-regulated the threonine
biosynthesis pathway by over-expressing the thrABC
opeon, cloned from the wild type E. coli or the threo-
nine producer E. coli ATCC 21277 that has a single
amino acid alteration in the homoserine dehydrogenase
(encoded by thrA
G1297A) for relieved feedback-inhibition
[28]. Transcriptional attenuation of those genes was
r e m o v e db yr e p l a c i n gt h en a t i v ep r o m o t e rw i t haT 7 lac
promoter, allowing for IPTG-inducible expression. In
addition, the pathways that compete with threonine for-
mation as well as degrade threonine were eliminated by
knocking out metA (encoding homoserine O-succinyl-
transferase) and tdh (encoding threonine dehydrogen-
ase) genes, yielding strain HCT 21.
Our results showed that there was essentially no dif-
ference in 3HV production between strains expressing
the wild type and feedback resistant thrA (data not
shown) probably because threonine did not accumulate
or its level was not high enough to exert a feedback
inhibition to ThrA. We also compared 3HV production
across three different E. coli strains, including HCT 10,
HCT 20, and HCT 21. The mutants HCT 20 and HCT
21 carrying only empty plasmids significantly reduced
acetate production to 0.22 g/L as opposed to 1.85 g/L
by HCT 10 (Figure 5); however, recombinant mutant
HCT 20 or HCT 21 containing the 3HV pathway pro-
duced as much acetate as the recombinant HCT 10, a
counterintuitive finding (see Discussion). The deletions
of metA and tdh enhanced (S)-3HV production by 41%
(recombinant HCT 21 relative to recombinant HCT 20),
but essentially had no effect on (R)-3HV production.
Nevertheless, those mutations were able to boost the
ratios of 3HV/3HB by decreasing the 3HB titers and/or
increase the 3HV titers. Overall, titers as high as
0.31 g/L and 0.50 g/L of (S)-3HV and (R)-3HV were
achieved in the recombinant HCT 21 with 3HV/3HB
ratios up to 0.35 and 0.24, respectively (Figure 5).
Figure 4 3HV biosynthesis from glucose and threonine.T h i s
figure shows shake-flask production of chiral 3HV by recombinant
E. coli strain HCT 10 grown in LB supplemented with 20 g/L glucose
and 3 g/L threonine. Chiral 3HV production using alternative
threonine deaminases (encoded by ilvA) from E. coli and C.
glutamicum is compared. All strains contained the same set of
plasmids pET-PB-B, pCOLA-Icg or pCOLA-Iec as indicated, and pCDF-
T-H (for (S)-3HV synthesis) or pCDF-T-P (for (R)-3HV synthesis).
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Glycerol has become a promising and abundant carbon
source due to its generation as an inevitable byproduct
of biodiesel production from vegetable oils or animal
fats through a transesterification reaction [29]. There
have been several reports on converting glycerol to
more valuable compounds such as thymidine, ethanol,
and 1,3-propanediol [30-32]. Glycerol is also more
reduced than glucose, leading to a higher reduced cofac-
tor pool in the cytoplasm [32]. Therefore, in addition to
glucose, we investigated the ability of our recombinant
E. coli to convert glycerol to chiral 3HV. Titers of 0.08
g/L and 0.96 g/L of (S)-3HV and (R)-3HV, respectively,
were achieved in recombinant HCT 10, while recombi-
nant HCT 21 produced 0.19 g/L and 0.60 g/L of (S)-
3HV and (R)-3HV, respectively (Figure 6). As mentioned
in the Materials and Methods section, in this specific
experiment, concentration of 3HB was quantified by
DAD at 210 nm that had a detection limit at around
0.08 g/L. As a result, the amounts of (S)-3HB produced
in both recombinant HCT 10 and HCT 21 strains were
too low to be quantified so that we could not report the
3HV/3HB ratios. Nonetheless, in the case of (R)-iso-
mers, 3HV/3HB ratios could be as high as 0.88 and
1.10, respectively, in recombinant HCT 10 and HCT 21
strains. The high 3HV/3HB ratios can be beneficial in
terms of product separation or biosynthesis of PHBV
that enables high 3HV content.
Confirmation of 3HV Stereochemistry
The stereochemistry of the resulting 3HV in the media
from these cultures was determined by methyl esterifica-
tion of the 3HV present followed by chiral HPLC
analysis using our previously developed method [15].
However, we could not assign an absolute stereochemis-
try to each sample due to the unavailability of enantio-
pure 3HV standards. However, based on our previous
results regarding the product stereochemistry of phaB
and hbd and the observation that Me-(R)-3HB has a fas-
ter retention time relative to Me-(S)-3HB, we expect
Me-(R)-3HV to have a faster retention time than Me-
(S)-3HV when analyzed by the same method. Thus, the
6.9 and 9.2 min peaks likely represent Me-(R)-3HV and
Me-(S)-3HV, respectively (Figure 7). These results con-
firm the enantiopurity of biosynthesized 3HV.
Discussion
In general, two approaches can be taken to engineer
E. coli for direct 3HV production via the threonine bio-
synthesis pathway. The first is to utilize an existing
threonine producer, such as E. coli ATCC 21277 [33],
followed by further engineering to introduce our con-
structed 3HV pathway. However, this and other avail-
able threonine producing strains have typically been
developed through multiple rounds of random mutagen-
esis and selection due to the difficulty of engineering
this highly regulated and complex metabolic network.
Although there are several successful cases in develop-
ing industrial threonine producers by such approaches,
resultant strains usually also suffer from undesired phe-
notypes including, for example, growth retardation, low
transformation efficiency, and by-product formation as a
result of random mutations [34]. In addition, other
uncharacterized mutations may hinder further strain
development as often needed. Fortunately, recent
Figure 5 3HV biosynthesis solely from glucose.T h i sf i g u r e
shows shake-flask production of chiral 3HV in various knock-out
strains as described in Table 1. Cells were grown in LB
supplemented with 20 g/L glucose. The top and bottom dashed
lines represent the acetate titers produced from E. coli strain HCT 10
and HCT 20 harboring empty plasmids, respectively. All strains
contained the same set of plasmids pET-PB-B, pCOLA-Tecm-Icg, and
pCDF-T-H (for (S)-3HV synthesis) or pCDF-T-P (for (R)-3HV synthesis).
The recombinant HCT 10 strains carrying an empty pCOLAduet-1 in
place of pCOLA-Tecm-Icg, as control strains, produced essentially no
3HV (data not shown).
Figure 6 3HV biosynthesis solely from glycerol.T h i sf i g u r e
shows shake-flask production of chiral 3HV in various knock-out
strains as described in Table 1. Cells were grown in LB
supplemented with 20 g/L glycerol. The amounts of (S)-3HB
produced in both recombinant HCT 10 and HCT 21 strains were too
low to be quantified due to a low detection limit by DAD at 210
nm; therefore, the 3HV/3HB ratios were not applicable (NA) to the
(S)-isomer. All strains contained the same set of plasmids pET-PB-B,
pCOLA-Tecm-Icg, and pCDF-T-H (for (S)-3HV synthesis) or pCDF-T-P
(for (R)-3HV synthesis).
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rational development of production strains [34]. There-
fore, as a second approach, a genetically-defined threo-
nine producing strain was established and introduced
with the 3HV pathway to achieve direct microbial pro-
duction of chiral 3HV from glucose or glycerol.
As seen in Figure 5 acetate is the major byproduct to
the production of hydroxyacids (3HB and 3HV). In an
effort to decrease acetate and increase 3HV production,
a mutant strain HCT 20 with deletions on atoDA, poxB,
and ackA-pta genes was developed. Counter-intuitively,
the recombinant acetate pathway knockout strains of
H C T2 0a n dH C T2 1p r o d u c e ds l i g h t l ym o r ea c e t a t e
and less 3HB than recombinant HCT 10. We suspected
that the enzymatic activity responsible for acetate pro-
duction was restored by Ptb-Buk and TesB in the
recombinant HCT 20 and HCT 21. In fact, in a separate
experiment, both enzymes were found to have CoA-
removing activities on acetyl-CoA and propionyl-CoA
(data not shown), so an introduction of TesB and/or
Ptb-Buk to strains HCT 20 or HCT 21 would likely
restore the ability to produce acetate.
Apparently, knocking out enzymes responsible for
acetate production failed to reduce acetate synthesis.
Alternatively, to alleviate the substrate promiscuity of
TesB and Ptb-Buk on acetyl-CoA, and thus reduce
acetate production, one approach called enzyme co-
localization could be implemented to allow substrate
channeling between enzymes [35]. For example, pathway
enzymes of Hbd and TesB, catalyzing successive reac-
tions, can be co-localized in an attempt to reduce the
amount of freely floating TesB that may hydrolyze
acetyl-CoA as well as to increase accessibility of 3HV-
CoA by TesB. The spatial organization of the enzymes
can be achieved using either the leucine zipper, a dimer
resulting from interaction between leucine residues [36],
or the synthetic scaffolds, constructed from protein-pro-
tein interaction domains [37]. Furthermore, expressing
enzymes that would assimilate produced acetate is
another way to reduce acetate accumulation. For exam-
ple, acetyl-CoA synthetase (encoded by acs)f r o mE. coli
can be over-expressed to convert acetate to acetyl-CoA
with the use of one ATP. While successfully demon-
strated in one work [38], in our case, over-expression of
acs was found to have essentially no effect on acetate
reduction (data not shown). Additionally, to overcome
the hurdle of acetate reduction, approaches like protein
engineering of TesB and/or Ptb-Buk to alleviate their
substrate promiscuity, or utilization of better isozymes
with more stringent substrate specificity could also miti-
gate the carbon loss in the form of acetate.
Among microbes, NADH and NADPH play a central
role in energy metabolism by providing the cell with the
reducing power for a variety of cellular redox reactions.
The availability of such cofactors could impose a huge
impact on the functionality of introduced biosynthetic
pathways. In fact, we have previously shown that the
NADPH/NADP
+ ratio was two- to three-fold higher
than the NADH/NAD
+ ratio under the culture condi-
tions examined, presumably affecting in vivo activities of
PhaB and Hbd and resulting in greater production of
(R)-3HB than (S)-3HB [15]. Given that our proposed
3HV pathway was based on the previously established
3HB pathway, it was also expected to see the same
trend of greater production of (R)-3HV than (S)-3HV,
even though the cofactor dependency of 3HV synthesis
may be complicated by the energetically expensive
threonine biosynthesis pathway with utilization of both
ATP and NADPH. In an effort to perturb the cofactor
balance within the cells, thereby tuning the production
of (R)-3HV and (S)-3HV, we attempted to used glycerol,
a promising, abundant, and highly-reduced carbon
source, to support 3HV production. Based on our calcu-
lation of reducing equivalents (e
-) of glucose and
glycerol, on the same basis of 2 moles of phosphoenol-
pyruvate synthesized, glucose and glycerol possess,
respectively, 24 and 28 reducing equivalents. Potentially,
the additional four reducing equivalents can be utilized
to generate two NADPH or equivalent amount of ATP.
Figure 7 Determination of the stereochemistry of 3HV.H P L C
spectra of (A) racemic 3HV standards after boiling in methanol, (B)
culture medium from the recombinant strain HCT 10 expressing
bktB, phaB, tesB, and ptb-buk after boiling in methanol, and (C)
culture medium from the recombinant strain HCT 10 expressing
bktB, hbd, tesB, and ptb-buk after boiling in methanol are shown.
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higher intracellular NADPH/NADP
+ ratio was observed
when glycerol was used as a carbon source than glucose,
and this higher ratio was also reflected in boosted pro-
duction of thymidine as its biosynthesis requires
NADPH as a cofactor [32]. Given that both NADPH
and ATP play a central role in threonine biosynthesis,
we hypothesized that the use of glycerol, which could
generate more NADPH and ATP (Figure 1) relative to
glucose, may favor threonine biosynthesis by directing
more carbon flux towards production of propionyl-CoA,
thus favoring the formation of 3HV relative to 3HB. In
agreement with our hypothesis, a higher 3HV/3HB ratio
was obtained in the (R)-3HV production when glycerol
was used as the carbon source (Figure 6). In addition,
much larger ratios of the total (R)-hydroxyacids (sum-
mation of (R)-3HB and (R)-3HV titers) to the total (S)-
hydroxyacids (summation of (S)-3HB and (S)-3HV
titers) were observed in glycerol-fed cultures (Figure 6)
compared to glucose-fed cultures (Figure 5). We
hypothesize that the higher intracellular NADPH/NADP
+ ratio as a result of the use of glycerol would favor (R)-
hydroxyacid biosynthesis compared to the use of
glucose, thus yielding the larger ratios of total (R)-
hydroxyacids to total (S)-hydroxyacids.
As mentioned previously, BktB was chosen as the pri-
mary thiolase due to its high enzymatic specificity
towards the C5 substrate. Given that E. coli has an endo-
genous thiolase (encoded by atoB), a deletion of atoB
was expected to increase the ratio of 3HV/3HB as AtoB
has been shown to prefer to condense two molecules of
acetyl-CoA instead of one propionyl-CoA and one
acetyl-CoA [19]. However, our preliminary result
showed that the recombinant HCT 11 with an atoB
deletion behaved exactly as the recombinant HCT 10,
and the deletion in atoB had essentially no effect on
3HV production (data not shown), implying that atoB
may not be a constitutively expressed gene. In addition,
it is noteworthy that increased 3HV production in the
recombinant HCT 20 relative to the recombinant HCT
10 was observed only with 2-ketobutyrate supplementa-
tion (Figure 3) but not with the threonine supplementa-
tion, solely glucose, or solely glycerol experiments
(Figure 4, 5 and 6); similarly, an accumulation of propio-
nate only occurred in the 2-ketobutyrate supplementa-
tion experiment (Figure 3), altogether, indicating that
3HV biosynthesis from glucose or glycerol is most likely
limited by the precursor propionyl-CoA. Therefore,
approaches to increase the availability of propionyl-CoA
could enhance the 3HV production.
Conclusions
Carbon skeletons with even-chain number are naturally
found in fatty acid metabolism, but those with odd-chain
number are pretty novel. As a result, there is a good deal
of interest in making odd-carbon chain molecules such
as 3HV (C5) and propionate (C3) because they are so
much harder to get to than even-carbon chain ones such
as acetate (C2) and butyrate/butanol (C4). This paper
opens the way for biosynthesis of the odd-carbon chain
molecules from renewable feedstocks. Taking together,
our work represents the first report of direct microbial
production of enantiomerically pure 3HV from a single
carbon source. In addition, we have explored the produc-
tion of each stereoisomer of 3HV across different geneti-
cally altered E. coli strains, along with various enzyme
homologs, for enhanced chiral 3HV production. Further
engineering of host strains and pathway enzymes should
lead to higher 3HV titers and a more economical biopro-
cess for the production of chiral 3HV.
Methods
Microorganisms
The bacterial strains used are listed in Table 1. C. aceto-
butylicum ATCC 824, C. glutamicum ATCC 13032, and
a threonine hyper-producer E. coli ATCC 21277 were
purchased from the American Type Culture Collection
(ATCC, Manassas, VA). R. eutropha H16 was provided
by Professor Anthony Sinskey of the Department of
Biology at the Massachusetts Institute of Technology
(Cambridge, MA, USA). E. coli DH10B (Invitrogen,
Carlsbad, CA) and ElectroTen-Blue (Stratagene, La Jolla,
CA) were used for transformation of cloning reactions
and propagation of all plasmids. MG1655 (kindly
donated by Professor Gregory Stephanopoulos of the
Department of Chemical Engineering at the Massachu-
setts Institute of Technology, USA) was used as the par-
ental strain for genetic modification. Host gene
deletions of endA, recA, atoDA, ackA-pta, poxB, tdh,
metA,a n datoB were achieved with P1t r a n s d u c t i o n
using the Keio collection strains as donor cells [39]. The
kanamycin cassette was removed using plasmid pCP20
as described by Datsenko and Wanner [40] and the suc-
cessfully constructed mutant strains were verified by
colony PCR using appropriate primers. Strains carrying
a lDE3 lysogen were constructed using a lDE3 Lyso-
genization Kit (Novagen, Darmstadt, Germany) for site-
specific integration of lDE3 prophage into each host.
Plasmid Construction
Genes derived from C. acetobutylicum ATCC 824 (hbd
and ptb-buk operon), R. eutropha H16 (bktB and phaB),
C. glutamicum ATCC 13032 (ilvA), E. coli MG1655
(tesB, ilvA, and thrABC opeon), and E. coli ATCC
21277 (thrA
G1297ABC opeon) were obtained by polymer-
ase chain reaction (PCR) using genomic DNA (gDNA)
templates. All gDNAs were prepared using the Wizard
Genomic DNA Purification Kit (Promega, Madison,
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Page 8 of 12WI). Custom oligonucleotides (primers) were purchased
for all PCR amplifications (Sigma-Genosys, St. Louis,
MO) as listed in Table 1. In all cases, Phusion High
Fidelity DNA polymerase (Finnzymes, Espoo, Finland)
was used for DNA amplification. Restriction enzymes
and T4 DNA ligase were purchased from New England
Biolabs (Ipswich, MA). Recombinant DNA techniques
were performed according to standard procedures [41].
Three co-replicable vectors, pETDuet-1, pCDFDuet-1,
and pCOLADuet-1 (Novagen, Darmstadt, Germany),
were used for construction of chiral 3HV biosynthetic
pathways [42]. All vectors contain two multiple cloning
Table 1 E. coli strains, plasmids and oligonucleotides used
Name Relevant Genotype Reference
Strains
DH10B F
- mcrA Δ(mrr-hsdRMS-mcrBC) j80lacZΔM15 ΔlacX74 recA1 endA1 araD139Δ(ara, leu)7697 galU galK l
-
rpsL nupG
Invitrogen
ElectroTen-Blue Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac Kan
r [F’ proAB lacI
qZΔM15
Tn10 (Tet
r)]
Stratagene
MG1655 F
- l
- ilvG- rfb-50 rph-1 ATCC 700926
HCT 10 MG1655 ΔendA ΔrecA (DE3) This study
HCT 11 MG1655 ΔendA ΔrecA ΔatoB (DE3) This study
HCT 20 MG1655 ΔendA ΔackA-pta ΔatoDA ΔpoxB (DE3) This study
HCT 21 MG1655 ΔendA ΔackA-pta ΔatoDA ΔpoxB ΔmetA Δtdh (DE3) This study
Plasmids
pETDuet-1 ColE1(pBR322) ori, lacI,T 7 lac, Amp
R Novagen
pCDFDuet-1 CloDF13 ori, lacI,T 7 lac, Strep
R Novagen
pCOLADuet-1 COLA ori, lacI,T 7 lac, Kan
R Novagen
pET-B pETDuet-1 harboring bktB from R. eutropha H16 This study
pET-PB-B
a pETDuet-1 harboring ptb-buk operon from C. acetobutylicum ATCC 824, and bktB from R. eutropha H16 This study
pCDF-H pCDFDuet-1 harboring hbd from C. acetobutylicum ATCC 824 This study
pCDF-T-H
a pCDFDuet-1 harboring tesB from E. coli MG1655, and hbd from C. acetobutylicum ATCC 824 This study
pCDF-P pCDFDuet-1 harboring phaB from R. eutropha H16 This study
pCDF-T-P
a pCDFDuet-1 harboring tesB from E. coli MG1655, and phaB from R. eutropha H16 This study
pCOLA-Iec pCOLADuet-1 harboring ilvA from E. coli MG1655 This study
pCOLA-Icg pCOLADuet-1 harboring ilvA from C. glutamicum This study
pCOLA-Tec-Icg
a pCOLADuet-1 harboring thrABC operon from E. coli MG1655, and ilvA from C. glutamicum ATCC 13032 This study
pCOLA-Tecm-Icg
a pCOLADuet-1 harboring thrA
G1297ABC operon from E. coli ATCC 21277, and ilvA from C. glutamicum
ATCC 13032
This study
Primers
b Sequence 5’®3’
c
bktB_US_EcoRI GAATTCATGACGCGTGAAGTGGTAGTG Sigma-Genosys
bktB_DS_XhoI CTCGAGCGCAAGGCTAACCTCAGAT Sigma-Genosys
hbd_US_NdeI ATTCATATGAAAAAGGTATGTGTTATAGG Sigma-Genosys
hbd_DS_AvrII ATTCCTAGGCAGGTCGACTCTAGAACTTA Sigma-Genosys
phaB_US_MfeI ATTCAATTGACGAAGCCAATCAAGGAG Sigma-Genosys
phaB_DS_AvrII ATTCCTAGGGGTCAGCCCATATGCAG Sigma-Genosys
tesB_US_NcoI ATTCCATGGGCATGAGTCAGGCGCTAA Sigma-Genosys
tesB_DS_NotI ATTGCGGCCGCGACTCTAGAGACTTAATTGTG Sigma-Genosys
ilvAec_US_NdeI ATTACATATGGCTGACTCGCAAC Sigma-Genosys
ilvAec_DS_AvrII ATTACCTAGGCATTTTTCCCTAACC Sigma-Genosys
ilvAcg_US_NdeI ATTACATATGAGTGAAACATACGTGTC Sigma-Genosys
ilvAcg_DS_AvrII ATTACCTAGGCCTTCAGCTATGTTTA Sigma-Genosys
thrABC_US_BamHI ATTAGGATCCAAGGAGATATATCATGCGAGTGTTGAAG Sigma-Genosys
thrABC_US_NcoI ATTACCATGGGCATGCGAGTGTTGAAG Sigma-Genosys
thrABC_DS_SalI ATTAGTCGACGATAATGAATAGATTTTACTGATG Sigma-Genosys
a Each gene is under the control of the T7lac promoter with a ribosome binding site.
b Primers were synthesized at Sigma-Genosys, St. Louis, MO.
c Restriction enzyme sites used in the cloning are shown in underlined italics.
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Page 9 of 12sites (MCS), each of which is preceded by a T7lac pro-
moter and a ribosome binding site (RBS), affording
high-level expression of each individual gene.
Plasmids constructed in the present work are listed in
Table 1. For cloning genes, PCR products incorporated
with desired restriction sites within the 5’ and 3’ primers
were digested, and the resulting DNA fragments were
then cloned into pETDuet-1, pCDFDuet-1, or pCOLA-
Duet-1. The bktB gene was inserted in between the MfeI
and XhoI sites (MCS II) of pETDuet-1 to create pET-B.
The ptb-buk gene, digested from pCDF-PB with EcoRI
and NotI [15], was inserted between the EcoRI and NotI
sites (MCS I) of pET-B to create pET-PB-B. Plasmid
pCDF-H was created by inserting the hbd gene between
the NdeI and AvrII sites (MCS II) of pCDFDuet-1. Clon-
ing the tesB gene between the NcoI and NotI sites (MCS
I) of pCDFDuet-1 resulted in plasmid pCDF-T. Plasmid
pCDF-T-H was then created by inserting the hbd gene
between the NdeIa n dAvrII sites (MCS II) of pCDF-T.
In a similar manner, plasmid pCDF-P was created by
inserting the phaB gene between the MfeIa n dAvrII
sites (MCS II) of pCDFDuet-1. Plasmid pCDF-T-P was
created by inserting the phaB gene between the MfeI
and AvrII sites (MCS II) of pCDF-T. Plasmids of
pCOLA-Iec and pCOLA-Icg were constructed by insert-
ing the E. coli ilvA and C. glutamicum ilvA, respectively,
between the NdeIa n dAvrII sites (MCS II) of pCOLA-
Duet-1. The thrABC operon from MG1655 was inserted
in between the NcoIa n dSalIs i t e s( M C SI )o fp C O L A -
Duet-1 to create pCOLA-Tec. Plasmid pCOLA-Tec-Icg
was then created by inserting the C. glutamicum ilvA
gene between the NdeIa n dAvrII sites (MCS II) of
pCOLA-Tec. To construct plasmid pCOLA-Tecm-Icg,
the thrA
G1997ABC operon from E. coli ATCC 21277 was
inserted in between the BamHIa n dSalIs i t e s( M C SI )
of pCOLA-Icg. All constructs were confirmed to be cor-
rect by restriction enzyme digestion and nucleotide
sequencing.
Culture Conditions
Seed cultures of the recombinant strains were grown in
LB medium at 30°C overnight on a rotary shaker at 250
rpm. For the biosynthesis of chiral 3HV, the seed cul-
tures were used to inoculate 50 mL LB medium supple-
mented with 20 g/L glucose or 20 g/L glycerol at an
inoculation volume of 2% in 250 mL flasks. Cultures
were then incubated at 30°C on a rotary shaker until
OD600 reached 0.8~1.0. At this point, 1 mM IPTG was
added to the cultures to induce recombinant protein
expression. Following induction, cells were cultivated at
30°C and sampled at 24 h intervals for up to 72 h post-
induction for HPLC analysis. We found that both 3HB
and 3HV titers did not reach a plateau until 48 h and
that there was essentially no difference in the titers
between 48 h and 72 h. Accordingly, only the peak titers
observed at 48 h were reported in this study. In some
experiments as indicated, 20 mM (~1.92 g/L) sodium
propionate, 3 g/L sodium 2-ketobutyrate, or 3 g/L threo-
nine was added into the cultures at the same time of
induction. In all cases, LB medium was supplemented with
50 mg/L ampicillin, 50 mg/L streptomycin, and 30 mg/L
kanamycin, as appropriate. In general, experiments were
performed in triplicates, and data are presented as the
averages and standard deviations of the results.
Metabolite Analysis
Samples were centrifuged to pellet cells while the aqueous
supernatant was collected for HPLC analysis. Products of
interest, including 3HB, 3HV, glucose, glycerol, 2-ketobu-
tyrate, acetate, and propionate, were analyzed via HPLC
using an Agilent 1100 series instrument equipped with a
refractive index detector (RID) and a diode array detector
(DAD). Given that the 3HB peak is overlapped with the
glycerol peak in the RID chromatogram, detection of 3HB
in the glycerol-fed cultures was achieved using the DAD at
210 nm. Analyte separation was achieved using an Ami-
nex® HPX-87 H anion exchange column (Bio-Rad Labora-
tories, Hercules, CA) with 5 mM H2SO4 as the mobile
phase. The mobile phase was pumped at a constant rate of
0.6 mL/min, and the column and detector temperatures
were each set at 35°C throughout. Concentrations were
determined by linear extrapolation from calibration of
external standards.
Chiral Analysis of 3HV
The stereochemistry of 3HV produced was determined
by methyl esterification of the 3HV present in the med-
ium followed by chiral HPLC analysis as described in a
previously reported method [15]. The chiral analysis was
performed on an Agilent 1100 Series instrument
equipped with a Chiralcel OD-H column (0.46 cm j ×2 5
cm) purchased from Daicel Chemical Industries (West
Chester, PA). Methyl-3HV was detected on a DAD at
210 nm. The mobile phase was 9:1 n-hexane:isopropanol
and the flow rate through the column was 0.7 mL/min.
Due to unavailability of standards of Methyl-(R)-3HV
and Methyl-(S)-3HV, these spectra were compared to a
racemic 3HV standard (Epsilon Chimie, Brest, France)
derivatized by methyl esterification.
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